Ruth Link-Gelles, PhD, MPH, of the CDC's National Center for Immunization and Respiratory Diseases, who has been leading the ...

Vaxcyte Inc. (NASDAQ:PCVX) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. On June ...

The US appears to be turning its back on a scientific consensus that has relegated several diseases to history ...

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.

The decision shows just how vaccine critics are beginning to shape official U.S. policy, public health officials told The Washington Post.

In contrast to earlier conferences in 2025, experts interviewed as part of the BIO conference in Boston did not come to a ...

Donald Trump’s Health Secretary, Robert F. Kennedy Jr., reduced a key government immunizations committee to a “talk show” by ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...